Raymundo
Ocaranza Sánchez
Complejo Hospitalario de Toledo
Toledo, EspañaPublications in collaboration with researchers from Complejo Hospitalario de Toledo (4)
2022
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
2021
-
Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis
Cardiovascular Revascularization Medicine, Vol. 31, pp. 1-6
-
Real-world registry of the durable Angiolite fluoroacrylate polymer-based sirolimus-eluting stent: The EPIC02 – RANGO study
REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 258-266
2014
-
Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction
Thrombosis and Haemostasis, Vol. 112, Núm. 4, pp. 716-726